CASIA OpenIR  > 中国科学院分子影像重点实验室
Deep Learning-Based Prediction of Future Extrahepatic Metastasis and Macrovascular Invasion in Hepatocellular Carcinoma
Fu, Sirui1,2; Pan, Meiqing2,3; Zhang, Jie4; Zhang, Hui2,3,5; Tang, Zhenchao2,3,5; Li, Yong1; Mu, Wei2,3,5; Huang, Jianwen1; Dong, Di3; Duan, Chongyang6; Li, Xiaoqun7; Wang, Shuo2,3; Chen, Xudong8; He, Xiaofeng9; Yan, Jianfeng10; Lu, Ligong1; Tian, Jie2,3,5,11
发表期刊JOURNAL OF HEPATOCELLULAR CARCINOMA
2021
卷号8页码:1065-1076
通讯作者Lu, Ligong(llg0902@sina.com) ; Tian, Jie(tian@ieee.org)
摘要Purpose: For timely treatment of extrahepatic metastasis and macrovascular invasion (aggressive progressive disease [PD]) in hepatocellular carcinoma, models aimed at stratifying the risks of subsequent aggressive PD should be constructed. Patients and Methods: After dividing 332 patients from five hospitals into training (n = 236) and validation (n = 96) datasets, non-invasive models, including clinical/semantic factors (Model(CS)), deep learning radiomics (Model(D)), and both (Model(CSD)), were constructed to stratify patients according to the risk of aggressive PD. We examined the discrimination and calibration; similarly, we plotted a decision curve and devised a nomogram. Furthermore, we performed analyses of subgroups who received different treatments or those in different disease stages and compared time to aggressive PD and overall survival in the high- and low-risk subgroups. Results: Among the constructed models, Model(CSD), combining clinical/semantic factors and deep learning radiomics, outperformed Model(CS) and Model(D) (areas under the curve [AUCs] for the training dataset: 0.741, 0.815, and 0.856; validation dataset: 0.780, 0.836, and 0.862), with statistical difference per the net reclassification improvement, the integrated discrimination improvement, and/or the DeLong test in both datasets. Besides, Model(CSD) had the best calibration and decision curves. The performance of Model(CSD) was not affected by treatment types (AUC: resection = 0.839; transarterial chemoembolization = 0.895; p = 0.183) or disease stages (AUC: BCLC [Barcelona Clinic Liver Cancer] stage 0 and A = 0.827; BCLC stage AB &B = 0.861; p = 0.537). Moreover, the high-risk group had a significantly shorter median time to aggressive PD than the low-risk group (training dataset hazard ratio [HR] = 0.108, p < 0.001; validation dataset HR = 0.058, p < 0.001) and poorer overall survival (training dataset HR = 0.357, p < 0.001; validation dataset HR = 0.204, p < 0.001). Conclusion: Our deep learning-based model successfully stratified the risks of aggressive PD. In the high-risk population, current guideline indicates that first-line treatments are insufficient to prevent extrahepatic metastasis and macrovascular invasion and ensure survival benefits, so more therapies may be explored for these patients.
关键词aggressive disease progression deep learning radiomics clinical factors high-risk risk prediction
DOI10.2147/JHC.S319639
关键词[WOS]SURVIVAL BENEFIT ; LIVER RESECTION ; CANCER
收录类别SCI
语种英语
资助项目National Key R&D Program of China[2017YFA0205200] ; National Key R&D Program of China[2017YFC1308700] ; National Natural Science Foundation of China[62027901] ; National Natural Science Foundation of China[82001914] ; National Natural Science Foundation of China[81871511] ; Project of High-Level Talents Team Introduction in Zhuhai City[Zhuhai HLHPTP201703] ; Nurture Programme of Zhuhai People's Hospital[2019-PY-07] ; Nurture Programme of Zhuhai People's Hospital[2020XSYC-09]
项目资助者National Key R&D Program of China ; National Natural Science Foundation of China ; Project of High-Level Talents Team Introduction in Zhuhai City ; Nurture Programme of Zhuhai People's Hospital
WOS研究方向Oncology
WOS类目Oncology
WOS记录号WOS:000692832400001
出版者DOVE MEDICAL PRESS LTD
七大方向——子方向分类医学影像处理与分析
引用统计
被引频次:5[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.ia.ac.cn/handle/173211/45966
专题中国科学院分子影像重点实验室
通讯作者Lu, Ligong; Tian, Jie
作者单位1.Jinan Univ, Zhuhai Hosp, Zhuhai Peoples Hosp, Zhuhai Intervent Med Ctr, 79 Kangning Rd, Zhuhai 519000, Guangdong, Peoples R China
2.Beihang Univ, Sch Engn Med, Beijing Adv Innovat Ctr Big Data Based Precis Med, Beijing 100191, Peoples R China
3.Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, CAS Key Lab Mol Imaging,Beijing Key Lab Mol Imag, Beijing, Peoples R China
4.Jinan Univ, Zhuhai Hosp, Zhuhai Peoples Hosp, Dept Radiol, Zhuhai, Peoples R China
5.Beihang Univ, Minist Ind & Informat Technol, Key Lab Big Data Based Precis Med, Beijing, Peoples R China
6.Southern Med Univ, Sch Publ Hlth, Dept Biostat, Guangzhou, Peoples R China
7.Zhongshan City Peoples Hosp, Dept Intervent Treatment, Zhongshan, Peoples R China
8.Shenzhen Peoples Hosp, Dept Radiol, Shenzhen, Peoples R China
9.Southern Med Univ, Nanfang Hosp, Intervent Diag & Treatment Dept, Guangzhou, Peoples R China
10.Yangjiang Peoples Hosp, Dept Radiol, Yangjiang, Peoples R China
11.Univ Chinese Acad Sci, Beijing, Peoples R China
通讯作者单位中国科学院自动化研究所
推荐引用方式
GB/T 7714
Fu, Sirui,Pan, Meiqing,Zhang, Jie,et al. Deep Learning-Based Prediction of Future Extrahepatic Metastasis and Macrovascular Invasion in Hepatocellular Carcinoma[J]. JOURNAL OF HEPATOCELLULAR CARCINOMA,2021,8:1065-1076.
APA Fu, Sirui.,Pan, Meiqing.,Zhang, Jie.,Zhang, Hui.,Tang, Zhenchao.,...&Tian, Jie.(2021).Deep Learning-Based Prediction of Future Extrahepatic Metastasis and Macrovascular Invasion in Hepatocellular Carcinoma.JOURNAL OF HEPATOCELLULAR CARCINOMA,8,1065-1076.
MLA Fu, Sirui,et al."Deep Learning-Based Prediction of Future Extrahepatic Metastasis and Macrovascular Invasion in Hepatocellular Carcinoma".JOURNAL OF HEPATOCELLULAR CARCINOMA 8(2021):1065-1076.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Fu, Sirui]的文章
[Pan, Meiqing]的文章
[Zhang, Jie]的文章
百度学术
百度学术中相似的文章
[Fu, Sirui]的文章
[Pan, Meiqing]的文章
[Zhang, Jie]的文章
必应学术
必应学术中相似的文章
[Fu, Sirui]的文章
[Pan, Meiqing]的文章
[Zhang, Jie]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。